<DOC>
	<DOCNO>NCT00782080</DOCNO>
	<brief_summary>This study determine safety efficacy herbal treatment child adolescent ADHD . Study Design : - Randomized - Double Blind ( Subject , Caregiver , Investigator , Outcomes Assessor ) - Placebo Control - Parallel Assignment</brief_summary>
	<brief_title>Efficacy Safety St. John´s Wort/Valerian Extract Versus Placebo Children Adolescents With ADHD</brief_title>
	<detailed_description>ADHD common childhood disorder associate attention problem disruptive behavior . Clinical evidence suggest herbal drug combination St. John´s Wort /Valerian extract may effective treat ADHD symptom methylphenidate atomoxetine naive patient . This study determine safety efficacy herbal treatment child adolescent ADHD . Participants randomly assign receive either herbal product placebo twice day duration 8 week . Participants come study visit 2 8 week assessment ADHD symptom , performance spontaneous movement . Side effect monitor continuously also assess rating scale .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>DSMIV Diagnosis ADHD Score ADHDRSIVParent Version ≥24 Sufficient knowledge German language Written Informed Consent parent patient Ability swallow study medication Sexually mature active adolescent highly effective method birth control : contraception accord PearlIndex &lt; 1 use oral contraceptive , additional method contraception ( e.g . condom ) necessary , i.e . doublebarrier Known hypersensitivity St. John´s wort Valerian root one excipients Known hypersensitivity skin expose sunlight All serious internal disease , reason : Current intake follow medication : Ciclosporin , Tacrolimus , Indinavir protease inhibitor antiHIV treatment Irinotecan cytostatics anticoagulant Cumarintype , Digoxin , Amitriptylin , Nortriptyline Midazolam , Theophylline medication photosensitive effect All severe psychiatric disease except oppositional defiant disorder ( accord item 2128 SNAPIV ) conduct disorder ( accord item 4145 SNAPIV ) , reason current intake follow medication : antidepressant psychotropic medication Indication hospitalization Suicidality ( include suicidal thought ) : Score ≥3 item 10 MADRS Pregnancy , lactation IQ &lt; 70 Positive screening metabolite illegal drug urine Previous medication stimulant and/or atomoxetine Psychotropic comedication Placement institution official judicial ruling Parallel participation another clinical trial accord German Drug Law ( AMG ) , less 4 week ago Patients require primary medication methylphenidate study period 8 week</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>ADHD</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>St. John ` Wort</keyword>
	<keyword>Valerian extract</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>